68 related articles for article (PubMed ID: 9376578)
1. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
Harousseau JL; Cahn JY; Pignon B; Witz F; Milpied N; Delain M; Lioure B; Lamy T; Desablens B; Guilhot F; Caillot D; Abgrall JF; Francois S; Briere J; Guyotat D; Casassus P; Audhuy B; Tellier Z; Hurteloup P; Herve P
Blood; 1997 Oct; 90(8):2978-86. PubMed ID: 9376578
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between induction chemotherapy cycles and prognosis in patients with acute myeloid leukemia].
Zhao T; Zhang Y; Yang S; Bao L; Wang J; Jiang H; Zhu H; Jia J; Lu J; Jiang B; Huang X; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):89-94. PubMed ID: 25778880
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of early intensified induction chemotherapy and standard 3+7 chemotherapy in adult patients with acute myeloid leukemia.
Yoon JH; Kim HJ; Kwak DH; Min GJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Blood Res; 2017 Sep; 52(3):174-183. PubMed ID: 29043232
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features and survival analysis of patients with CD56 expression in de- novo acute myeloid leukemia with t（8;21）].
Liu S; Wei X; Mi R; Ai H; Yin Q; Wang P; Wang X; Fan R; Hu J; Zhu X; Zhou J; Fu Y; Song Y
Zhonghua Xue Ye Xue Za Zhi; 2015 Aug; 36(8):676-81. PubMed ID: 26462638
[TBL] [Abstract][Full Text] [Related]
5. Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report.
Miyaoka T; Wake R; Hashioka S; Hayashida M; Oh-Nishi A; Azis IA; Izuhara M; Tsuchie K; Araki T; Arauchi R; Abdullah RA; Horiguchi J
Front Psychiatry; 2017; 8():174. PubMed ID: 28983259
[TBL] [Abstract][Full Text] [Related]
6. When the devil is in the details: Similarities and differences between WHO and ICC classifications of AML.
Ramos-Cillan S; Láinez-González D; Solan L; Blas C; Salgado R; Castaño T; Cornago J; Llamas P; Alonso-Dominguez JM
Leuk Res; 2024 Feb; 137():107440. PubMed ID: 38244295
[No Abstract] [Full Text] [Related]
7. Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML.
Ge S; Wang J; He Q; Zhu J; Liu P; Wang H; Zhang F
Ann Hematol; 2024 Jan; ():. PubMed ID: 38267560
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation followed by interleukin-2 for adult acute myeloid leukemia patients with favorable or intermediate risk after complete remission.
Zeng Q; Xiang B; Liu Z
Ann Hematol; 2022 Aug; 101(8):1711-1718. PubMed ID: 35570208
[TBL] [Abstract][Full Text] [Related]
9. History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia.
Gorin NC
Clin Hematol Int; 2021 Sep; 3(3):83-95. PubMed ID: 34820613
[TBL] [Abstract][Full Text] [Related]
10. Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation.
Mulé MP; Mannis GN; Wood BL; Radich JP; Hwang J; Ramos NR; Andreadis C; Damon L; Logan AC; Martin TG; Hourigan CS
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1974-1982. PubMed ID: 27544285
[TBL] [Abstract][Full Text] [Related]
11. Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
Krug U; Berdel WE; Gale RP; Haferlach C; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Staib P; Beelen D; Serve H; Schliemann C; Stelljes M; Balleisen L; Maschmeyer G; Grüneisen A; Eimermacher H; Giagounidis A; Rasche H; Hehlmann R; Lengfelder E; Thiel E; Reichle A; Aul C; Ludwig WD; Kern W; Haferlach T; Köpcke W; Görlich D; Sauerland MC; Heinecke A; Wörmann BJ; Hiddemann W; Büchner T
Leukemia; 2016 Jun; 30(6):1230-6. PubMed ID: 26859081
[TBL] [Abstract][Full Text] [Related]
12. Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR.
Mizutani M; Hara M; Fujita H; Aoki J; Kanamori H; Ohashi K; Usuki K; Fukuda T; Chou T; Tanaka J; Atsuta Y; Takami A
Bone Marrow Transplant; 2016 May; 51(5):645-53. PubMed ID: 26808566
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia.
Ossenkoppele GJ; Janssen JJ; van de Loosdrecht AA
Haematologica; 2016 Jan; 101(1):20-5. PubMed ID: 26721801
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects.
Gorin NC; Giebel S; Labopin M; Savani BN; Mohty M; Nagler A
Bone Marrow Transplant; 2015 Dec; 50(12):1495-502. PubMed ID: 26281031
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies.
Li D; Wang L; Zhu H; Dou L; Liu D; Fu L; Ma C; Ma X; Yao Y; Zhou L; Wang Q; Wang L; Zhao Y; Jing Y; Wang L; Li Y; Yu L
PLoS One; 2015; 10(7):e0132620. PubMed ID: 26197471
[TBL] [Abstract][Full Text] [Related]
16. T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.
Gorin NC; Labopin M; Piemontese S; Arcese W; Santarone S; Huang H; Meloni G; Ferrara F; Beelen D; Sanz M; Bacigalupo A; Ciceri F; Mailhol A; Nagler A; Mohty M;
Haematologica; 2015 Apr; 100(4):558-64. PubMed ID: 25637051
[TBL] [Abstract][Full Text] [Related]
17. Progress in acute myeloid leukemia.
Kadia TM; Ravandi F; O'Brien S; Cortes J; Kantarjian HM
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):139-51. PubMed ID: 25441110
[TBL] [Abstract][Full Text] [Related]
18. High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.
Hengeveld M; Suciu S; Chelgoum Y; Marie JP; Muus P; Lefrère F; Mandelli F; Pane F; Amadori S; Fioritoni G; Labar B; Baron F; Cermak J; Bourhis JH; Storti G; Fazi P; Hagemeijer A; Vignetti M; Willemze R; de Witte T
Bone Marrow Transplant; 2015 Mar; 50(3):341-7. PubMed ID: 25402418
[TBL] [Abstract][Full Text] [Related]
19. High-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis.
Li W; Gong X; Sun M; Zhao X; Gong B; Wei H; Mi Y; Wang J
PLoS One; 2014; 9(10):e110153. PubMed ID: 25299623
[TBL] [Abstract][Full Text] [Related]
20. Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Nagler A; Labopin M; Gorin NC; Ferrara F; Sanz MA; Wu D; Gomez AT; Lapusan S; Irrera G; Guimaraes JE; Sousa AB; Carella AM; Vey N; Arcese W; Shimoni A; Berger R; Rocha V; Mohty M
Haematologica; 2014 Aug; 99(8):1380-6. PubMed ID: 24816236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
